Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis

[1]  Wei Zhou,et al.  Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. , 2015, The Lancet. Oncology.

[2]  Nitin A. Pagedar,et al.  Association of sentinel lymph node biopsy with survival for head and neck melanoma: survival analysis using the SEER database. , 2014, JAMA otolaryngology-- head & neck surgery.

[3]  A. Eggermont,et al.  Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients. , 2014, European journal of cancer.

[4]  R. Botella-Estrada,et al.  Correlation of histologic regression in primary melanoma with sentinel node status. , 2014, JAMA dermatology.

[5]  S. Mocellin,et al.  Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma. , 2014, JAMA surgery.

[6]  A. Hauschild,et al.  Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study. , 2014, The Lancet. Oncology.

[7]  M. Schön,et al.  Sentinel Node Biopsy Improves Prognostic Stratification in Patients with Thin (pT1) Melanomas and an Additional Risk Factor , 2014, Annals of Surgical Oncology.

[8]  A. Stratigos,et al.  Emerging trends in the epidemiology of melanoma , 2014, The British journal of dermatology.

[9]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[10]  S. Mocellin,et al.  The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  V. Sondak,et al.  Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Metastasis Among Young and Old Patients , 2014, Annals of Surgical Oncology.

[12]  D. Elder,et al.  Clark Level Risk Stratifies Patients with Mitogenic Thin Melanomas for Sentinel Lymph Node Biopsy , 2014, Annals of Surgical Oncology.

[13]  V. Sondak,et al.  Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Ross,et al.  Impact of the 2009 (7th Edition) AJCC Melanoma Staging System in the Classification of Thin Cutaneous Melanomas , 2013, BioMed research international.

[15]  Michael E. Egger,et al.  Outcomes and prognostic factors in superficial spreading melanoma. , 2013, American journal of surgery.

[16]  M. Akiyama,et al.  Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node , 2013, Journal of cutaneous pathology.

[17]  A. Rademaker,et al.  A 10-year, single-institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas. , 2013, Journal of the American Academy of Dermatology.

[18]  A. Halpern,et al.  Melanoma, Version 2.2013 Featured Updates to the NCCN Guidelines , 2013 .

[19]  M. Nosrati,et al.  Analysis of sentinel lymph node positivity in patients with thin primary melanoma. , 2013, Journal of the American Academy of Dermatology.

[20]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[21]  R. Roumen,et al.  Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years’ experience in two regional training hospitals in the Netherlands , 2013, International Journal of Clinical Oncology.

[22]  G. Botti,et al.  Sentinel Node Biopsy in Thin and Thick Melanoma , 2013, Annals of Surgical Oncology.

[23]  S. Leachman,et al.  Sentinel Lymph Node Biopsy for Melanoma in Pregnant Women , 2013, Annals of Surgical Oncology.

[24]  Donald L Weaver,et al.  Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  V. Sondak,et al.  Sentinel Node Biopsy is Indicated for Thin Melanomas ≥0.76 mm , 2012, Annals of Surgical Oncology.

[26]  Byron C. Wallace,et al.  Closing the Gap between Methodologists and End-Users: R as a Computational Back-End , 2012 .

[27]  K. Shannon,et al.  Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma , 2012, Annals of surgery.

[28]  T. Eberlein,et al.  Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation , 2012 .

[29]  A. Hauschild,et al.  Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  T. Höller,et al.  Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  M. Middleton,et al.  Sentinel lymph node biopsy in melanoma: The Oxford ten year clinical experience. , 2011, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[32]  G. Lyman,et al.  Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M. Shoup,et al.  Predictors of positive sentinel lymph node in thin melanoma. , 2011, American journal of surgery.

[34]  P. Feustel,et al.  Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience , 2011, Head & neck.

[35]  I. Efstratiou,et al.  Is 0.75 mm Breslow thickness the correct cut-off point for performing sentinel node biopsy in patients with melanoma? , 2010, Hellenic journal of nuclear medicine.

[36]  C. Berking,et al.  Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma , 2010, Melanoma research.

[37]  C. Corless,et al.  Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes. , 2010, American journal of surgery.

[38]  P. Payoux,et al.  Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patients , 2009, The British journal of dermatology.

[39]  L. Vermeeren,et al.  Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value. , 2010, European journal of dermatology : EJD.

[40]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[42]  J. Avilés-Izquierdo,et al.  [Sentinel node biopsy as a prognostic factor in cutaneous melanoma]. , 2009, Actas dermo-sifiliograficas.

[43]  S. Mocellin,et al.  Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM–IMI) , 2009, Annals of Surgical Oncology.

[44]  R. Turner,et al.  Importance of sentinel lymph node biopsy in patients with thin melanoma. , 2008, Archives of surgery.

[45]  D. Roulin,et al.  Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[46]  C. Ingvar,et al.  Sentinel node biopsy in malignant melanoma: Swedish experiences 1997–2005 , 2008, Acta oncologica.

[47]  T. Vahlberg,et al.  Sentinel Lymph Node Biopsy in Cutaneous Melanoma: A Case-Control Study , 2007, Annals of Surgical Oncology.

[48]  C. Kaur,et al.  The correlation of regression in primary melanoma with sentinel lymph node status , 2007, Journal of Clinical Pathology.

[49]  B. Balda,et al.  Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: A follow‐up study of 148 patients , 2007, International journal of cancer.

[50]  R. Cecchi,et al.  Sentinel lymph node biopsy in patients with thin melanomas , 2007, The Journal of dermatology.

[51]  P. G. Lang,et al.  American Joint Committee on Cancer Clinical Stage as a Selection Criterion for Sentinel Lymph Node Biopsy in Thin Melanoma , 2007 .

[52]  P. G. Lang,et al.  Sentinel-Node Biopsy or Nodal Observation in Melanoma , 2007 .

[53]  N. Cascinelli,et al.  Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  J. J. Coleman,et al.  The Prognostic Importance of Sentinel Lymph Node Biopsy in Thin Melanoma , 2006, Annals of Surgical Oncology.

[55]  D. Elder,et al.  Predictors of Regional Nodal Disease in Patients With Thin Melanomas , 2006, Annals of Surgical Oncology.

[56]  D. Coit,et al.  Results of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma , 2006, Annals of Surgical Oncology.

[57]  K. Heine Stokholm,et al.  Sentinel node biopsy in cutaneous melanoma , 2006, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[58]  J. Lang.  Mitotic Rate as a Predictor of Sentinel Lymph Node Positivity in Patients With Thin Melanomas , 2006 .

[59]  M. Fernández-Figueras,et al.  Single‐Institution Experience in the Management of Patients with Clinical Stage I and II Cutaneous Melanoma: Results of Sentinel Lymph Node Biopsy in 240 Cases , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[60]  V. Sondak,et al.  Sentinel node biopsy for thin melanomas: which patients should be considered? , 2005, Cancer control : journal of the Moffitt Cancer Center.

[61]  S. Swetter,et al.  Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. , 2005, Archives of dermatology.

[62]  H. Kittler,et al.  Sentinel node status in melanoma patients is not predicitive for overall survival upon multivariate analysis , 2005, British Journal of Cancer.

[63]  K. Drzewiecki,et al.  Sentinel node biopsy for melanoma: a study of 241 patients , 2004, Melanoma research.

[64]  C. Garbe,et al.  Micrometastasis of a Sentinel Lymph Node in Cutaneous Melanoma Is a Significant Prognostic Factor for Disease‐Free Survival, Distant‐Metastasis‐Free Survival, and Overall Survival , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[65]  T. Hensing,et al.  Indications for Lymphatic Mapping and Sentinel Lymphadenectomy in Patients with Thin Melanoma (Breslow Thickness ≤1.0 mm) , 2004, Annals of Surgical Oncology.

[66]  David Elder,et al.  Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  M. Ross,et al.  Lessons learned from the Sunbelt Melanoma Trial , 2004, Journal of surgical oncology.

[68]  Jeremy MG Taylor,et al.  Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model , 2004, Annals of Surgical Oncology.

[69]  M. Ross,et al.  Complications Associated With Sentinel Lymph Node Biopsy for Melanoma , 2003, Annals of Surgical Oncology.

[70]  M. Walker,et al.  Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. , 2003, Surgery.

[71]  W. McCarthy,et al.  Prognosis for patients with thin cutaneous melanoma , 2003, Cancer.

[72]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[73]  Jeffrey E. Lee,et al.  Revised American Joint Committee on Cancer Staging Criteria Accurately Predict Sentinel Lymph Node Positivity in Clinically Node-Negative Melanoma Patients , 2003, Annals of Surgical Oncology.

[74]  I. Jacobs,et al.  Role of Sentinel Lymph Node Biopsy in Patients With Thin (<1 mm) Primary Melanoma , 2003, Annals of Surgical Oncology.

[75]  P. Manson,et al.  Sentinel Lymph Node Biopsy for the T1 (Thin) Melanoma: Is It Necessary? , 2003, Annals of plastic surgery.

[76]  L. Cornelius,et al.  Sentinel lymph node biopsy in patients with thin melanoma. , 2003, Archives of dermatology.

[77]  L. Ferreira,et al.  Vertical growth phase and positive sentinel node in thin melanoma. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[78]  P. Rutkowski,et al.  Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes – one institution's experience , 2003, Melanoma research.

[79]  D. Krag,et al.  Lymphoscintigraphy and Sentinel Node Biopsy Accurately Stage Melanoma in Patients Presenting After Wide Local Excision , 2003, Annals of Surgical Oncology.

[80]  J. A. Bishop,et al.  British Association of Dermatologists Clinical Standards Unit. Revised U.K. guidelines for the management of cutaneous melanoma , 2010 .

[81]  T. Kageshita,et al.  Sentinel Lymph Nodes Study in 30 Cases of Melanoma , 2001, The Journal of dermatology.

[82]  P. V. van Diest,et al.  No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm , 2001, Melanoma research.

[83]  W. Gillanders,et al.  Melanoma thickness and histology predict sentinel lymph node status. , 2001, American journal of surgery.

[84]  A. Testori,et al.  Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience , 2000, Annals of Surgical Oncology.